Affinage

TMEM65

Transmembrane protein 65 · UniProt Q6PI78

Length
240 aa
Mass
25.5 kDa
Annotated
2026-06-10
16 papers in source corpus 13 papers cited in narrative 13 extracted findings
Cross-family judge vs UniProt: Affinage preferred faithfulness: 7/7 claims corpus-supported (100%)

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

TMEM65 is an integral protein of the mitochondrial inner membrane, targeted there by an N-terminal signal that is cleaved by the matrix processing protease, and it serves as the principal effector of Na+-dependent mitochondrial Ca2+ extrusion (PMID:24765583, PMID:40691517). Reconstitution of purified TMEM65 in liposomes demonstrates that the protein itself functions as the mitochondrial Na+/Ca2+ exchanger (mito-NCX): it forms a homodimer with ion-coordinating residues essential for activity, drives Na+/Ca2+ exchange when expressed in cells lacking native mito-NCX, and harbors the binding site for the inhibitor CGP-37157 (PMID:40691517). Consistent with this catalytic identity, TMEM65 enhances Na+- and Li+-dependent Ca2+ efflux that is blocked by CGP-37157 (PMID:41408045), and proximity proteomics and co-fractionation place it adjacent to and in direct association with NCLX within a common macromolecular complex (PMID:37873405, PMID:40200126). Loss of TMEM65 ablates Na+-dependent Ca2+ export, drives mitochondrial Ca2+ overload, primes the permeability transition, and causes necrotic cell death, whereas overexpression protects against Ca2+ stress (PMID:40691517, PMID:41980949). Genetic epistasis establishes TMEM65 downstream of the mitochondrial calcium uniporter: MCU knockout rescues the early lethality of whole-body Tmem65-null mice and suppresses thermal-stress necrosis in C. elegans lacking TMEM65 homologs (PMID:41408045, PMID:41980949). Tissue-specific ablation produces seizure-associated sudden death and neuronal phenotypes, skeletal myopathy, and impaired cardiac and neuromuscular function (PMID:40200126, PMID:41980949), and a homozygous splice variant causes human mitochondrial encephalomyopathy with reduced respiratory capacity (PMID:28295037). In cardiomyocytes TMEM65 additionally localizes to the intercalated disc, where it interacts with connexin 43 to maintain gap-junction stability and with the sodium-channel β1 subunit (SCN1B) to organize the perinexal nanodomain and proper localization of NaV1.5 and Cx43, such that its loss slows cardiac conduction and produces cardiomyopathy (PMID:26403541, PMID:36257954).

Mechanistic history

Synthesis pass · year-by-year structured walk · 12 steps
  1. 2014 High

    Establishing where TMEM65 resides was the first step in assigning it any function; the work fixed it as an inner-membrane protein with a cleavable targeting signal.

    Evidence Orthogonal biochemical fractionation (alkali/digitonin extraction), immunostaining, and deletion-mutant targeting analysis of isolated mitochondria

    PMID:24765583

    Open questions at the time
    • No molecular function or transport activity assigned
    • Topology and oligomeric state within the inner membrane not defined
  2. 2015 High

    Beyond mitochondria, TMEM65 was found at the cardiac intercalated disc as a Cx43 partner, defining an unexpected role in gap-junction maintenance and cardiac conduction.

    Evidence Plasma-membrane proteomics, reciprocal Co-IP, shRNA knockdown in neonatal cardiomyocytes, and zebrafish morpholino knockdown

    PMID:26403541

    Open questions at the time
    • Mechanism linking a mitochondrial inner-membrane protein to an ICD pool unresolved
    • Whether ICD localization reflects a distinct protein population not addressed
  3. 2017 Medium

    A human loss-of-function variant tied TMEM65 to disease and to respiratory-chain capacity, confirming functional importance in patient cells.

    Evidence Patient fibroblast fractionation, siRNA knockdown, and oxygen consumption/respirometry

    PMID:28295037

    Open questions at the time
    • Molecular basis of the respiratory defect not mechanistically defined
    • Single patient/single lab
  4. 2022 High

    The cardiac role was extended in vivo: TMEM65 binds the sodium-channel β1 subunit and is required for perinexal nanodomain assembly and conduction, linking its loss to progressive cardiomyopathy.

    Evidence AAV9-shRNA mouse knockdown, Co-IP, super-resolution microscopy, ECG/echocardiography, optical mapping, and patch-clamp electrophysiology

    PMID:36257954

    Open questions at the time
    • How TMEM65 organizes the nanodomain at the molecular level unknown
    • Relationship between ICD and mitochondrial functions not reconciled
  5. 2022 Medium

    Transcriptional control of TMEM65 was placed under a CHD6–TCF4 axis coupled to mitochondrial dynamics and ATP output.

    Evidence ChIP and Co-IP at the TMEM65 promoter, CHD6 knockdown/knockout mice, reporter assays, and xenograft/PDX models

    PMID:36473865

    Open questions at the time
    • Direct mechanism by which TMEM65 affects mitochondrial dynamics not shown
    • Generality of this regulation across tissues unclear
  6. 2023 Medium

    Proximity proteomics reframed TMEM65 as an NCLX-proximal regulator of mitochondrial Ca2+ efflux, with loss causing Ca2+ overload and permeability transition.

    Evidence BioID proteomics, Ca2+ flux assays with pharmacological/genetic NCLX inhibition, co-fractionation, in silico modeling, and AAV-shRNA mouse knockdown (preprint)

    PMID:37873405

    Open questions at the time
    • Whether TMEM65 is a regulator versus the transporter itself unresolved at this stage
    • Direct binding not yet distinguished from proximity
  7. 2025 High

    Peer-reviewed work confirmed TMEM65 as a direct NCLX binding partner enhancing Na+-dependent Ca2+ efflux, with in vivo overload phenotypes in heart and muscle.

    Evidence Proximity proteomics, Ca2+ efflux assays, pharmacological/genetic NCLX manipulation, and AAV-shRNA mouse models with cardiac/neuromuscular assays

    PMID:40200126

    Open questions at the time
    • Did not establish whether TMEM65 has intrinsic transport activity
    • Stoichiometry of the TMEM65–NCLX complex undefined
  8. 2025 High

    The catalytic identity was resolved: purified, liposome-reconstituted TMEM65 is itself the mitochondrial Na+/Ca2+ exchanger, acting as a homodimer with defined ion-coordinating residues.

    Evidence Homodimerization assays, site-directed mutagenesis, heterologous expression in mito-NCX-null cells, protein purification with liposome reconstitution, and CGP-37157 binding-site mapping

    PMID:40691517

    Open questions at the time
    • Atomic structure of the transporter not reported
    • Functional relationship between intrinsic TMEM65 activity and NCLX requires reconciliation
  9. 2025 High

    Pharmacology and cross-species genetics confirmed TMEM65-dependent Na+/Li+-driven Ca2+ extrusion and positioned TMEM65 downstream of MCU in a Ca2+-overload death pathway.

    Evidence Mitochondrial Ca2+ imaging with gain/loss-of-function, CGP-37157 inhibition, and C. elegans MCU-1 epistasis

    PMID:41408045

    Open questions at the time
    • NCLX-independent versus NCLX-dependent activity not fully reconciled with binding data
    • Conditions selecting one mode over another unclear
  10. 2025 High

    Conditional knockout mice defined tissue-specific physiological consequences and cemented the MCU-downstream placement via MCU-rescue of lethality.

    Evidence Whole-body, neuronal, and muscle-specific conditional knockouts, Ca2+ flux assays, MCU double-knockout epistasis, survival analysis, and electrophysiology/histology

    PMID:41980949

    Open questions at the time
    • Cell-autonomous basis of seizure/sudden-death phenotype not dissected
    • Link between Ca2+ handling and ICD/conduction roles not integrated
  11. 2025 Medium

    In cancer contexts TMEM65 was connected to OXPHOS/ROS-driven stemness and to oncogenic signaling, defining roles distinct from its core transport function.

    Evidence siRNA/overexpression with OXPHOS/ROS readouts, HIF1α/SERPINB3 assays, MYC/TET3 manipulation (idx 10); Co-IP and YWHAZ-rescue with PI3K–Akt–mTOR markers and xenograft models (idx 6)

    PMID:38341472 PMID:40546127

    Open questions at the time
    • Whether these effects are downstream of mitochondrial Ca2+ handling unknown
    • Cytoplasmic YWHAZ interaction not reconciled with inner-membrane localization
    • Single-lab studies
  12. 2020 Medium

    TMEM65 depletion was shown to trigger mitochondrial stress responses, indicating its loss perturbs mitochondrial proteostasis and redox state.

    Evidence siRNA knockdown in human cells with ROS assays, qRT-PCR, and Western blot for UPRmt and import-receptor markers

    PMID:33319071

    Open questions at the time
    • Causal link between Ca2+ overload and UPRmt activation not established
    • Single method (knockdown) with marker readouts

Open questions

Synthesis pass · forward-looking unresolved questions
  • How TMEM65's intrinsic mito-NCX transport activity, its direct association with NCLX, and its distinct intercalated-disc/Cx43/SCN1B functions are mechanistically integrated remains unresolved.
  • No atomic structure of the transporter or of the TMEM65–NCLX complex
  • Mechanism allowing one protein to act at both inner membrane and ICD undefined
  • Whether cancer-associated signaling roles depend on Ca2+ transport unknown

Mechanism profile

Synthesis pass · controlled-vocabulary classification · explore literature graph →
Molecular activity
GO:0005215 transporter activity 4 GO:0140104 molecular carrier activity 2
Localization
GO:0005739 mitochondrion 2 GO:0005886 plasma membrane 2
Pathway
GO:0005829 cytosol 1

Evidence

Reading pass · 13 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
2014 TMEM65 is an integral protein of the mitochondrial inner membrane. Immunoblot, immunostaining, alkali extraction, and digitonin extraction of isolated mitochondria established its mitochondrial inner-membrane localization. The N-terminal region (residues 1–20) is sufficient for mitochondrial targeting, and the mitochondrial targeting signal is cleaved between residues 35 and 64 by matrix processing protease (MPP). Immunoblot, immunostaining, alkali extraction, digitonin fractionation of isolated mitochondria, deletion-mutant analysis PeerJ High 24765583
2015 TMEM65 localizes to the intercalated disc (ICD) of cardiomyocytes and physically interacts with connexin 43 (Cx43). shRNA-mediated Tmem65 knockdown in mouse neonatal cardiomyocytes causes internalization of Cx43 away from the ICD, shortens Cx43 half-life through increased degradation, and abolishes Cx43 gap-junction function. Morpholino knockdown in zebrafish recapitulates gap-junction dysfunction and cardiac morphology defects. Cationic silica-bead plasma-membrane enrichment + shotgun proteomics, lentiviral shRNA knockdown, co-immunoprecipitation, immunofluorescence, zebrafish morpholino knockdown Nature communications High 26403541
2017 A homozygous splice variant (c.472+1G>A) in TMEM65 causes mitochondrial encephalomyopathy in a patient. Subcellular fractionation confirmed TMEM65 protein in the inner mitochondrial membrane of patient fibroblasts. siRNA knockdown of TMEM65 in fibroblasts severely reduced mitochondrial content and oxygen consumption rate, establishing a direct role for TMEM65 in mitochondrial respiratory chain function. Immunofluorescence, subcellular fractionation/immunoblot, siRNA knockdown, enzymatic respirometry, oxygen consumption rate measurement European journal of human genetics Medium 28295037
2022 Tmem65 physically interacts with the voltage-gated sodium channel β1 subunit (SCN1B/β1) at the ICD, and this interaction is required for the establishment of the perinexal nanodomain and for correct localization of NaV1.5 and Cx43 to ICDs. AAV9-shRNA-mediated Tmem65 knockdown (90% reduction) in mouse hearts caused eccentric hypertrophic cardiomyopathy progressing to dilated cardiomyopathy, slowed conduction, prolonged PR intervals and QRS duration, and reduced Ca2+ and K+ currents in cardiomyocytes. rAAV9 shRNA knockdown in mice, immunoprecipitation, super-resolution microscopy, echocardiography, electrocardiography, optical mapping, whole-cell patch clamp electrophysiology Nature communications High 36257954
2022 CHD6 chromatin remodeler binds the TCF4 transcription factor at the TMEM65 promoter and drives transcriptional expression of TMEM65; TMEM65 in turn affects mitochondrial dynamics and ATP production. EGF signaling stabilizes CHD6 by preventing GSK3β-mediated phosphodegron formation and FBXW7-mediated ubiquitination, while Wnt/TCF4-β-catenin signaling transcriptionally activates CHD6 itself. CHD6 knockdown and knockout (mouse Villin-specific), chromatin immunoprecipitation, co-immunoprecipitation of CHD6–TCF4, reporter assays, xenograft models, patient-derived xenograft drug treatment Cell discovery Medium 36473865
2023 TMEM65 is an NCLX-proximal protein at the mitochondrial inner membrane that potently enhances Na+-dependent mitochondrial Ca2+ efflux. Pharmacological NCLX inhibition or genetic NCLX deletion abolishes the TMEM65-dependent increase in Ca2+ efflux. Loss-of-function studies show TMEM65 is required for Na+-dependent mitochondrial Ca2+ efflux. Co-fractionation and in silico structural modeling suggest TMEM65 and NCLX exist in a common macromolecular complex. Tmem65 knockdown in mice causes mitochondrial Ca2+ overload in heart and skeletal muscle and impairs cardiac and neuromuscular function. TMEM65 deletion causes excessive mitochondrial permeability transition; TMEM65 overexpression protects against necrotic cell death during Ca2+ stress. Proximity biotinylation (BioID) proteomics, Ca2+ flux assays, pharmacological NCLX inhibition (CGP-37157), genetic NCLX knockout, co-fractionation, in silico structural modeling, AAV-shRNA mouse knockdown, mitochondrial permeability transition assay bioRxivpreprint Medium 37873405
2024 TMEM65 directly binds YWHAZ (14-3-3ζ) in the cytoplasm, inhibiting ubiquitin-mediated degradation of YWHAZ, which in turn activates the PI3K–Akt–mTOR signaling pathway (evidenced by increased p-Akt, p-GSK-3β, p-mTOR). TMEM65 oncogenic effects in gastric cancer are partly dependent on YWHAZ. Co-immunoprecipitation (TMEM65–YWHAZ), Western blot for pathway activation markers, siRNA knockdown, ectopic overexpression, in vivo xenograft and lung-metastasis models, VNP-encapsulated siRNA delivery Oncogene Medium 38341472
2025 TMEM65 is identified as a direct NCLX binding partner that enhances Na+-dependent mitochondrial Ca2+ efflux. Genetic deletion of NCLX ablates TMEM65-dependent Ca2+ efflux, and TMEM65 knockdown in mice promotes mitochondrial Ca2+ overload in heart and skeletal muscle. TMEM65 loss impairs cardiac and neuromuscular function, and TMEM65 deletion causes mitochondrial permeability transition and cell death. Proximity biotinylation proteomic screening, Ca2+ efflux assays, pharmacological and genetic NCLX inhibition/deletion, AAV-shRNA mouse knockdown, in vivo cardiac and neuromuscular functional assays Nature metabolism High 40200126
2025 TMEM65 itself functions as the mitochondrial Na+/Ca2+ exchanger (mito-NCX). TMEM65 forms a homodimer containing putative ion-coordinating residues essential for function. Heterologous expression of TMEM65 alone induces Na+/Ca2+ exchange in cells lacking native mito-NCX activity. Purified, liposome-reconstituted TMEM65 exhibits key mito-NCX features (Na+-dependent Ca2+ exchange). The CGP-37157 binding site on TMEM65 was identified. TMEM65 deletion elevates mitochondrial Ca2+ and primes mitochondrial permeability transition. Biochemical homodimerization assays, site-directed mutagenesis of ion-coordinating residues, heterologous expression in mito-NCX-null cells, protein purification and liposome reconstitution, Ca2+ transport assay, CGP-37157 binding-site mapping, Ca2+ imaging Nature cell biology High 40691517
2025 TMEM65 overexpression specifically enhances Na+- and Li+-dependent mitochondrial Ca2+ extrusion in an NCLX-independent manner; this effect is inhibited by CGP-37157. TMEM65 downregulation chronically elevates basal mitochondrial [Ca2+] and impairs efflux upon stimulation. In C. elegans, deletion of TMEM65 homologs causes necrotic lesions under mild thermal stress that are suppressed by genetic inhibition of MCU-1, placing TMEM65 downstream of MCU in a Ca2+ overload pathway. Mitochondrial Ca2+ imaging (overexpression and knockdown), CGP-37157 pharmacological inhibition, C. elegans genetic deletion and MCU-1 epistasis, genetic suppression assay Nature communications High 41408045
2025 TMEM65 enhances mitochondrial oxidative phosphorylation (OXPHOS) and ROS production. Elevated ROS induces HIF1α, which transcriptionally activates SERPINB3, enhancing cancer stemness. MYC and TET3 coordinately upregulate TMEM65 transcription in triple-negative breast cancer. Pharmacological or siRNA-mediated inhibition of MYC or TET3 attenuates TMEM65-driven tumor progression. siRNA knockdown, ectopic overexpression, OXPHOS/ROS measurements, HIF1α reporter/Western blot, MYC/TET3 inhibitor treatment, in vivo tumor models Advanced science Medium 40546127
2025 Conditional whole-body and nervous system-specific Tmem65 knockout mice exhibit severe growth retardation and seizure-associated sudden death at ~3 weeks; skeletal muscle-specific knockout produces adult-onset myopathy with elevated mitochondrial Ca2+. TMEM65 ablation causes loss of Na+-dependent mitochondrial Ca2+ export. Genetic epistasis: MCU knockout rescues early lethality of whole-body Tmem65 knockout, extending lifespan from ~3 weeks to >1 year, placing TMEM65 function downstream of MCU in the mitochondrial Ca2+ overload pathway. Conditional knockout mouse generation (whole-body, neuronal, skeletal muscle-specific), mitochondrial Ca2+ measurements, Na+-dependent Ca2+ export assay, MCU double-knockout epistasis, survival analysis, electrophysiology, histology Nature communications High 41980949
2020 TMEM65 knockdown in human cultured cells induces mild ROS generation, oxidative stress response (upregulation of NFE2L2, SESN3), mild apoptosis, and mitochondrial unfolded protein response (UPRmt) with upregulation of HSPD1, LONP1. TOMM22 and HSPA9 protein levels are upregulated in an ATF5-independent manner following TMEM65 depletion. siRNA knockdown in human cells, ROS assay, qRT-PCR, Western blot for UPRmt markers and mitochondrial import receptors Biochemistry and biophysics reports Medium 33319071

Source papers

Stage 0 corpus · 16 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
2022 The chromatin remodeler CHD6 promotes colorectal cancer development by regulating TMEM65-mediated mitochondrial dynamics via EGF and Wnt signaling. Cell discovery 43 36473865
2015 Evolutionarily conserved intercalated disc protein Tmem65 regulates cardiac conduction and connexin 43 function. Nature communications 39 26403541
2014 TMEM65 is a mitochondrial inner-membrane protein. PeerJ 36 24765583
2025 TMEM65 regulates and is required for NCLX-dependent mitochondrial calcium efflux. Nature metabolism 33 40200126
2017 A mutation in the TMEM65 gene results in mitochondrial myopathy with severe neurological manifestations. European journal of human genetics : EJHG 27 28295037
2022 Tmem65 is critical for the structure and function of the intercalated discs in mouse hearts. Nature communications 19 36257954
2025 TMEM65 functions as the mitochondrial Na+/Ca2+ exchanger. Nature cell biology 18 40691517
2024 TMEM65 promotes gastric tumorigenesis by targeting YWHAZ to activate PI3K-Akt-mTOR pathway and is a therapeutic target. Oncogene 16 38341472
2023 TMEM65 regulates NCLX-dependent mitochondrial calcium efflux. bioRxiv : the preprint server for biology 11 37873405
2025 MYC/TET3-Regulated TMEM65 Activates OXPHOS-SERPINB3 Pathway to Promote Progression and Cisplatin Resistance in Triple-Negative Breast Cancer. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 10 40546127
2020 Depletion of TMEM65 leads to oxidative stress, apoptosis, induction of mitochondrial unfolded protein response, and upregulation of mitochondrial protein import receptor TOMM22. Biochemistry and biophysics reports 9 33319071
2025 TMEM65-dependent Ca2+ extrusion safeguards mitochondrial homeostasis. Nature communications 8 41408045
2025 Mitochondrial sodium-calcium exchange-Can TMEM65 do it alone? Cell metabolism 6 41061666
2025 Integrative multi-omics analysis N4-acetylcytidine modification landscape and the role of TMEM65 in breast cancer. International journal of biological macromolecules 2 40803458
2026 Loss of TMEM65 in mice causes mitochondrial disease mediated by mitochondrial Ca2. Nature communications 1 41980949
2026 Modified Banxia Xiexin Decoction promotes mitochondrial fission in colon cancer cells by inhibiting the CHD6-TMEM65 axis. Journal of ethnopharmacology 0 41663003

Missed literature

Know a paper Affinage missed for TMEM65? Flag it for the maintainers and the community.

No submissions yet.